At the end of a productive meeting, day, or week, I’m always asking myself, “what’s next.” Next on my calendar, next on my list, next on the agenda. Last year, I recognized that to get to what’s next as a foundation, I first had to learn, listen, and prepare.
I learned about the foundation’s core research mission and legacy of impact on new discoveries over the past 20 years. I listened to perspectives from patients, researchers, industry leaders, and MPN advocates on how we might advance our research mission together.
While I was learning and listening for the first half of the year, I was also preparing for the second half and beyond.
I organized around serving our stakeholders – patients and caregivers, researchers and clinicians, biopharmaceutical industry leaders, and the benefactors who generously enable our research mission. I sought out skilled leaders in philanthropy, rare disease patient advocacy and biopharma, and remain focused on bringing scientifically trained leaders to reinforce the research mission.
It may have looked different to the MPN community on the outside. Under the hood, the engine was revving!
In November, we were captivated by the outcomes of previously funded research at our 2021 MPN Roundtable, and we announced five new MPN Challenge